Hagenia abyssinica and Radiation exposure - from FDA reports
There is no Radiation exposure reported by people who take Hagenia abyssinica yet. This review analyzes which people have Radiation exposure with Hagenia abyssinica. It is created by eHealthMe based on reports from FDA, and is updated regularly.
What to expect?
Personalized health information
On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>
On Aug, 16, 2017
No report is found.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Subscribe to the study: get notified of updates to the study.
Do you have Radiation exposure when taking Hagenia abyssinica?
Expand the study to include all drugs with the same ingredientsRadiation exposure and drugs with ingredients of kousso.
Expand the study to include reports from both FDA and eHealthMeRadiation exposure and Hagenia abyssinica from FDA and eHealthMe reports
Hagenia abyssinica has active ingredients of kousso.
Radiation exposure has been reported by people with metastases to bone, rhabdomyosarcoma, prostate cancer, lower respiratory tract infection, coronary heart disease (latest reports from 45 Radiation exposure patients).